{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:02:33Z","timestamp":1765609353942},"reference-count":14,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2787,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2007.01690.x","type":"journal-article","created":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T05:04:12Z","timestamp":1201928652000},"page":"480-484","source":"Crossref","is-referenced-by-count":52,"title":["Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2\u2003years on"],"prefix":"10.1155","volume":"62","author":[{"given":"J.","family":"Usher-Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ramsbottom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Pearmain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2008,1,14]]},"reference":[{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1742-1241.2006.01217.x","article-title":"Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a Primary Care setting","volume":"61","author":"Usher-Smith","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1368-5031.2006.00903.x","article-title":"A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8\u2003mg, and losartan, 50\u2003mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring","volume":"60","author":"Baguet","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB3|cit3","first-page":"253","article-title":"Angiotensin II antagonists in the treatment of hypertension: more similarities than differences","volume":"2","author":"Conlin","year":"2000","journal-title":"J Clin Hypertens"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES Study)","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0895-7061(99)00142-9","article-title":"A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients","volume":"12","author":"Lacourciere","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1081\/CEH-200067668","article-title":"Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements","volume":"6","author":"Nishimura","year":"2005","journal-title":"Clin Exp Hypertens"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB8|cit8","first-page":"52","article-title":"Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group","volume":"1","author":"Gradman","year":"1999","journal-title":"Heart Dis"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/qshc.2003.007401","article-title":"Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK","volume":"13","author":"McElduff","year":"2004","journal-title":"Qual Saf Health Care"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/hrt.80.1.40","article-title":"Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Group","volume":"80","author":"Volmink","year":"1998","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(07)60025-7","article-title":"Cholesterol lowering in patients with CHD and metabolic syndrome","volume":"369","author":"Butler","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(07)60306-7","article-title":"Statins audit: wrong question, wrong conclusions","volume":"369","author":"Moon","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB13|cit13","first-page":"S80","article-title":"Therapeutic dose assessment of patient switching from atorvastatin to simvastatin","volume":"13","author":"Hess","year":"2007","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1742-1241.2007.01690.x-BIB14|cit14","first-page":"280","volume-title":"Brit J Cardiol","volume":"14","author":"Phillips","year":"2007"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2007.01690.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2007.01690.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:05:50Z","timestamp":1643349950000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2007.01690.x"}},"subtitle":["Clinical outcomes of switching drugs"],"short-title":[],"issued":{"date-parts":[[2008,1,14]]},"references-count":14,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01690.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,14]]}}}